PRESS: Celadon Pharmaceutical’s CEO Jim Short featured discussing new MHRA framework

Celadon Pharmaceuticals Plc’s CEO Jim Short featured discussing the new MHRA framework for UK domestic production of cannabis-based medicines. Celadon was proudly a pioneer in working with the regulators back in 2019-2020.
The new framework indicates a truly pharmaceutical direction of travel for the UK. This is Celadon’s approach: pharma-grade products, breakthrough R&D and clinical trials.
Read more over at BusinessCann by clicking here.
OTHER POSTS
-
PRESS: Britain could be getting high on the benefits of a full-scale medical cannabis industry
-
PRESS: British Pain Society features Celadon Pharmaceuticals Plc
-
BUSINESS UPDATE: Celadon Pharmaceuticals Plc (CEL) Announces Interim Results
-
PRESS: Inside huge top-secret legal cannabis facility hidden away in Birmingham that is the size of three football pitches